Novel functionalized pyrido[2,3-g]quinoxalinones as antibacterial, antifungal and anticancer agents

Farmaco

Volumn 56, Issue 12, 2001, Pages 933-938

  Carta, Antonio ^a   Sanna, Paolo ^a   Gherardini, Laura ^a   Usai, Donatella ^b   Zanetti, Stefania ^b  

^a Dipartimento Farmaco Chimico Tossicologico   (Italy)

^b Dipartimento di Scienze del Farmaco   (Italy)

Author keywords

Antibacterial; Anticancer activities; Anticandida; Pyrido 2,3 g quinoxalinones

Indexed keywords

ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; QUINOXALINE DERIVATIVE; INTERCALATING AGENT; PYRIDINE DERIVATIVE;

CONFERENCE PAPER; DRUG ACTIVITY; DRUG DETERMINATION; DRUG SCREENING; DRUG SYNTHESIS; IN VITRO STUDY; NONHUMAN; STRAIN DIFFERENCE; ARTICLE; CELL CULTURE; CHEMISTRY; HUMAN; MICROBIOLOGICAL EXAMINATION; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

ANTI-INFECTIVE AGENTS; ANTIFUNGAL AGENTS; ANTINEOPLASTIC AGENTS; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; INTERCALATING AGENTS; MICROBIAL SENSITIVITY TESTS; PYRIDINES; QUINOXALINES; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 0035664657     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-827X(01)01161-2     Document Type: Conference Paper

References (14)

1. Uber derivate des chinolinchinons-(5.8)
2. Heterocyclic quinones. VI: Synthesis and antitumoral effects of 5,10-benzo[g]quinoxalinediones and aza-analogues
3. Synthesis and cytotoxicity of 2-methyl-4,9-dihydro-1-substituted-1H-imidazo[4,5-g]quinoxaline-4,9-diones and 2,3-disubstituted-5,10-pyrazino[2,3-g]quinoxalinediones
4. Synthesis and cytotoxicity of 2-methyl-1-substituted-imidazo[4,5-g]quinoline-4,9-dione and 7,8-dihydro-10H-[1,4]oxazino[3′,4′:2,3]imidazo[4,5-g]quinoline- 5,12-dione derivatives
5. Bioactivation as a model for drug design bioreductive alkylation
6. Synthesis of substituted 2-ethoxycarbonyl- and 2-carboxyquinoxalin-3-ones for evaluation of antimicrobial and anticancer activity
7. Synthesis of 3,6,7-substituted-quinoxalin-2-ones for evaluation of antimicrobial and anticancer activity. Part 2
8. Preparation and biological evaluation of 6/7-trifluoromethyl(nitro)-, 6,7-difluoro-3-alkyl(aryl)-substituted-quinoxalin-2-ones. Part 3
9. Synthesis of two novel tricyclic rings: Triazolo[4,5-g]quinolines and pyrido[2,3-g]quinoxalines derived from 6,7-diaminoquinolines
10. Status of the NCI preclinical antitumor drug discovery screen